|Articles|July 28, 2009
Retina Roundtable Session 4
Advertisement
Subscribe
In this fourth session, the physicians discuss their strategies for managing the flow of patients coming in each month to receive their ranibizumab injections.
Participants include:
Return to
Return to
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ
2
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%.
3
EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved in Canada
4
Collarettes common but largely stable in moderate-to-severe dry eye patients
5













































.png)


